Elevated C-reactive protein is associated with sensory gating deficit in schizophrenia

Schizophrenia Research

Volumn 165, Issue 1, 2015, Pages 94-96

  Micoulaud Franchi, Jean Arthur ^c,d,e   Faugere, Mélanie ^a,b   Boyer, Laurent ^b   Fond, Guillaume ^f   Richieri, Raphaëlle ^a,b   Faget, Catherine ^a,b   Cermolacce, Michel ^a,c,g   Philip, Pierre ^d,e   Vion Dury, Jean ^a,c,g   Lancon, Christophe ^a,b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c HÔPITAL SAINTE MARGUERITE   (France)

^d BORDEAUX UNIVERSITY HOSPITAL   (France)

^e UNIVERSITÉ DE BORDEAUX   (France)

^f INSERM   (France)

^g CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; NEUROLEPTIC AGENT;

ADULT; AGED; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHIZOPHRENIA; SENSORY DYSFUNCTION; SENSORY GATING DEFICIT; ADOLESCENT; BLOOD; COGNITION DISORDERS; COMPLICATION; GAIT DISORDERS, NEUROLOGIC; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PSYCHOLOGICAL RATING SCALE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; C-REACTIVE PROTEIN; COGNITION DISORDERS; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84929511063     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2015.03.018     Document Type: Letter

References (10)

1. Boyer L., Richieri R., Dassa D., Boucekine M., Fernandez J., Vaillant F., Padovani R., Auquier P., Lancon C. Association of metabolic syndrome and inflammation with neurocognition in patients with schizophrenia. Psychiatry Res. 2013, 210(2):381-386.
2. Dickerson F., Stallings C., Origoni A., Boronow J., Yolken R. C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia. Schizophr. Res. 2007, 93(1-3):261-265.
3. Dickerson F., Stallings C., Origoni A., Vaughan C., Khushalani S., Yolken R. Additive effects of elevated C-reactive protein and exposure to herpes simplex virus type 1 on cognitive impairment in individuals with schizophrenia. Schizophr. Res. 2012, 134(1):83-88.
4. Dickerson F., Stallings C., Origoni A., Vaughan C., Khushalani S., Yang S., Yolken R. C-reactive protein is elevated in schizophrenia. Schizophr. Res. 2013, 143(1):198-202.
5. Fan X., Pristach C., Liu E.Y., Freudenreich O., Henderson D.C., Goff D.C. Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia. Psychiatry Res. 2007, 149(1-3):267-271.
6. Lindenmayer J.P., Khan A., Kaushik S., Thanju A., Praveen R., Hoffman L., Cherath L., Valdez G., Wance D. Relationship between metabolic syndrome and cognition in patients with schizophrenia. Schizophr. Res. 2012, 142(1-3):171-176.
7. Micoulaud-Franchi J.A., Hetrick W.P., Aramaki M., Bolbecker A., Boyer L., Ystad S., Kronland-Martinet R., Richieri R., Faget C., Faugere M., El-Kaim A., Cermolacce M., Lancon C., Vion-Dury J. Do schizophrenia patients with low P50-suppression report more perceptual anomalies with the sensory gating inventory?. Schizophr. Res. 2014, 157(1-3):157-162.
8. Miller B.J., Mellor A., Buckley P. Total and differential white blood cell counts, high-sensitivity C-reactive protein, and the metabolic syndrome in non-affective psychoses. Brain Behav. Immun. 2013, 31:82-89.
9. Miller B.J., Culpepper N., Rapaport M.H. C-reactive protein levels in schizophrenia: a review and meta-analysis. Clin. Schizophr. Relat. Psychoses 2014, 7(4):223-230.
10. Vuksan-Cusa B., Sagud M., Jakovljevic M. C-reactive protein and metabolic syndrome in patients with bipolar disorder compared to patients with schizophrenia. Psychiatr. Danub. 2010, 22(2):275-277.